At Recursion, we are pioneering the integration of technological innovations across biology, chemistry, automation, data science, and engineering to modernize drug discovery and development. Today we have 5 drugs in clinical trials, 2 in preclinical and 2 in late discovery. There are more than a dozen early discovery and research programs in oncology, neuroscience, inflammation & immunology, and rare disease. Since 2017, we have approximately doubled the capacity of our phenomics platform each year and scaled the number of executed phenomic experiments to up to 2.2 million every week, resulting in >21 petabytes of proprietary high-dimensional data. Reporting to the Associate Director of Engineering, for the Scientific Platforms in the Recursion OS, the Engineering Manager will work to provide first-in-class capabilities and infrastructure that provides robust, configurable, automatable experiment configuration and execution readiness on our Scientific Platforms Act as a mentor, coach, ...